Sweden

Effectiveness of Covid-19 Vaccination Against Risk of Symptomatic Infection, Hospitalization, and Death Up to 9 Months A Swedish Total-Population Cohort Study

Swedish Study on COVID 19 Vaccine Effectiveness Against Risk of Symptomatic Infection, Hospitalization, and Death

Nationwide Swedish study shows COVID 19 vaccine effectiveness wanes over time, in risk of symptomatic and severe COVID-19 infection.

November 27, 2021

End of content

No more pages to load